158 related articles for article (PubMed ID: 36557055)
1. Complete Cycle Mapping Using a Quantitative At-Home Hormone Monitoring System in Prediction of Fertile Days, Confirmation of Ovulation, and Screening for Ovulation Issues Preventing Conception.
Wegrzynowicz AK; Beckley A; Eyvazzadeh A; Levy G; Park J; Klein J
Medicina (Kaunas); 2022 Dec; 58(12):. PubMed ID: 36557055
[No Abstract] [Full Text] [Related]
2. The validation of the Billings ovulation method by laboratory research and field trials.
Billings JJ
Acta Eur Fertil; 1991; 22(1):9-15. PubMed ID: 1746210
[TBL] [Abstract][Full Text] [Related]
3. A Comparison of Two Hormonal Fertility Monitoring Systems for Ovulation Detection: A Pilot Study.
Mu Q; Fehring RJ
Medicina (Kaunas); 2023 Feb; 59(2):. PubMed ID: 36837601
[No Abstract] [Full Text] [Related]
4. Pilot Evaluation of a New Urine Progesterone Test to Confirm Ovulation in Women Using a Fertility Monitor.
Bouchard TP; Fehring RJ; Schneider M
Front Public Health; 2019; 7():184. PubMed ID: 31312631
[No Abstract] [Full Text] [Related]
5. Validation of urinary reproductive hormone measurements using a novel smartphone connected reader.
Pattnaik S; Das D; Venkatesan VA
Sci Rep; 2023 Jun; 13(1):9227. PubMed ID: 37286704
[TBL] [Abstract][Full Text] [Related]
6. Establishing a Gold Standard for Quantitative Menstrual Cycle Monitoring.
Bouchard T; Yong P; Doyle-Baker P
Medicina (Kaunas); 2023 Aug; 59(9):. PubMed ID: 37763632
[No Abstract] [Full Text] [Related]
7. Use of the Home Ovarian Monitor in pregnancy avoidance.
Brown JB; Holmes J; Barker G
Am J Obstet Gynecol; 1991 Dec; 165(6 Pt 2):2008-11. PubMed ID: 1755460
[TBL] [Abstract][Full Text] [Related]
8. Use of urinary pregnanediol 3-glucuronide to confirm ovulation.
Ecochard R; Leiva R; Bouchard T; Boehringer H; Direito A; Mariani A; Fehring R
Steroids; 2013 Oct; 78(10):1035-40. PubMed ID: 23831784
[TBL] [Abstract][Full Text] [Related]
9. Timing is crucial: Some critical thoughts on using LH tests to determine women's current fertility.
Lobmaier JS; Bachofner LM
Horm Behav; 2018 Nov; 106():A2-A3. PubMed ID: 30092174
[TBL] [Abstract][Full Text] [Related]
10. Monitoring of ovarian activity by daily measurement of urinary excretion rates of oestrone glucuronide and pregnanediol glucuronide using the Ovarian Monitor, Part III: variability of normal menstrual cycle profiles.
Blackwell LF; Vigil P; Cooke DG; d'Arcangues C; Brown JB
Hum Reprod; 2013 Dec; 28(12):3306-15. PubMed ID: 24170744
[TBL] [Abstract][Full Text] [Related]
11. The prediction and/or detection of ovulation by means of urinary steroid assays.
Cekan SZ; Beksac MS; Wang E; Shi S; Masironi B; Landgren BM; Diczfalusy E
Contraception; 1986 Apr; 33(4):327-45. PubMed ID: 3731775
[TBL] [Abstract][Full Text] [Related]
12. Identification and prediction of the fertile window with a new web-based medical device using a vaginal biosensor for measuring the circadian and circamensual core body temperature.
Regidor PA; Kaczmarczyk M; Schiweck E; Goeckenjan-Festag M; Alexander H
Gynecol Endocrinol; 2018 Mar; 34(3):256-260. PubMed ID: 29082805
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of menstrual cycles with or without intercourse in women with no known subfertility.
Najmabadi S; Schliep KC; Simonsen SE; Porucznik CA; Egger MJ; Stanford JB
Hum Reprod Open; 2022; 2022(4):hoac039. PubMed ID: 36186844
[TBL] [Abstract][Full Text] [Related]
14. Quantification of urinary total luteinizing hormone immunoreactivity may improve the prediction of ovulation time.
Demir A; Hero M; Holopainen E; Juul A
Front Endocrinol (Lausanne); 2022; 13():903831. PubMed ID: 36277692
[TBL] [Abstract][Full Text] [Related]
15. Progesterone and ovulation across stages of the transition to menopause.
O'Connor KA; Ferrell R; Brindle E; Trumble B; Shofer J; Holman DJ; Weinstein M
Menopause; 2009; 16(6):1178-87. PubMed ID: 19568209
[TBL] [Abstract][Full Text] [Related]
16. Monitoring of ovarian activity by measurement of urinary excretion rates using the Ovarian Monitor, Part IV: the relationship of the pregnanediol glucuronide threshold to basal body temperature and cervical mucus as markers for the beginning of the post-ovulatory infertile period.
Blackwell LF; Vigil P; Alliende ME; Brown S; Festin M; Cooke DG
Hum Reprod; 2016 Feb; 31(2):445-53. PubMed ID: 26677961
[TBL] [Abstract][Full Text] [Related]
17. Analyzing the atypical - Methods for studying the menstrual cycle in adolescents.
Klusmann H; Eisenlohr-Moul T; Baresich K; Schmalenberger KM; Girdler S; Andersen E
Psychoneuroendocrinology; 2023 Dec; 158():106389. PubMed ID: 37769538
[TBL] [Abstract][Full Text] [Related]
18. Early luteal phase treatment with mifepristone (RU 486) for fertility regulation.
Gemzell-Danielsson K; Swahn ML; Svalander P; Bygdeman M
Hum Reprod; 1993 Jun; 8(6):870-3. PubMed ID: 8345076
[TBL] [Abstract][Full Text] [Related]
19. An evaluation of the BIOSELF 110 fertility indicator.
Ismail M; Arshat H; Pulcrano J; Royston P; Spieler J
Contraception; 1989 Jan; 39(1):53-71. PubMed ID: 2642781
[TBL] [Abstract][Full Text] [Related]
20. Relationships between the luteinizing hormone surge and other characteristics of the menstrual cycle in normally ovulating women.
Direito A; Bailly S; Mariani A; Ecochard R
Fertil Steril; 2013 Jan; 99(1):279-285.e3. PubMed ID: 22999798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
